Novasep Appoints Fine Chemicals Market Director
News Jun 06, 2013
Novasep has announced that it has strengthened its position in the fine chemicals marketplace with the appointment of Udo Steinhauer as fine chemicals market director within the synthesis business unit of Novasep.
Udo Steinhauer has a strong industrial experience gained over 18 years in diverse managerial positions.
At Novasep, he will initially focus on four key business areas for Novasep: electronic, cosmetic, flavor and fragrance, and the polymer and biopolymer industry.
“The need for new organic synthesis and purification routes is now critical in the development of the specialty chemicals market,” said Udo Steinhauer.
Steinhauer continued, “As an example, the demand for new organic electronic chemicals in ultrapure quality is continuing to increase. Impurities in cosmetic active ingredients then have to be removed in order to avoid side effects. Another example is in the polymer industry. New additives are required to fulfill the demands of performance plastics and polymers obtained from new synthesis or purification routes of bio-based building blocks. I wanted to join Novasep, with its strong expertise and extended capabilities in organic synthesis and advanced purification, because it is an established player in these markets. It is able to offer a cost-effective response to these increasingly demanding manufacturing challenges.”
“Udo’s appointment is the next significant step in formalizing and developing Novasep’s position in these fine chemical markets,” said Michel Blanc, VP sales and business development of Novasep’s Synthesis Business Unit.
Blanc continued, “These industries require more and more skills in combining smart synthesis with high efficiency purification to develop innovative molecules.”
Novasep offers contract manufacturing solutions using an unparalleled array of specialized techniques that very few companies can handle at one time. This includes hazardous chemistry and large scale chromatography.
The technologies developed by Novasep often allow shorter synthetic pathways and therefore enable significant reduction of costs, time to market and environmental impact.
Novasep’s range of advanced purification techniques include membrane filtration, large scale HPLC, SMB and Varicol® continuous chromatography with integrated solvent recycling capabilities to drastically reduce operating costs.
The main reactions mastered at Novasep at industrial scale include oxidation, azides, nitration, the use of hydrazine, Grignards, alkyllithium, lithium aluminum hydride, carbon disulfide, nitroalkanes and carbonylation reactions.
By outsourcing with Novasep, clients can benefit from Novasep’s 140 years of experience in handling energetic and hazardous chemistry, thereby reducing risk and avoiding CAPEX.
The company offers a full range of integrated services including process development, scale-up and manufacturing from kilogram scale to 1,000’s of tons per year.
In addition to custom manufacturing services, Novasep also provides building blocks, intermediates and specialized reagents.
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
Agilent Technologies Presents Thought Leader Award to Dr. Ram SasisekharanNews
Agilent Technologies awards Dr. Ram Sasisekharan with the Agilent Thought Leader Award in recognition of his contributions in the field of biologics characterization.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018